Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction (CHOPIN)

Clinical Trial ID NCT00952744

PubWeight™ 3.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00952744

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med 2012 1.17
2 Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol 2013 1.13
3 Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med 2015 0.77
Next 100